HomeAI · summaries
Storia in 4 fonti
Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations
Maharashtra FDA cancelled Cipla's Pune unit drug sale licences. Serious irregularities in storage and recall procedures were cited by the regulator. The company failed to fully comply with market recall directions for Reactin Plus Tablets. Further non-compliance was discovered in the unit's distribution and sales system.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindu.com
FDA cancels drug sale licences of Cipla Pharma & Life Sciences' Pune Carry and Forwarding unit
FDA cancels Cipla Pharma's drug sale licenses due to serious storage and handling irregularities at its Pune unit.
- ·
economictimes.indiatimes.com
Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations
Maharashtra FDA cancelled Cipla's Pune unit drug sale licences. Serious irregularities in storage and recall procedures were cited by the regulator. The company failed to fully…
